Skip to main content
IMCR logo

IMCR · Immunocore Holdings plc

Track IMCR — free
$34.21 +0.01 (+0.03%) At close · Aug 14
Market Cap
$1.76B
Shares
51.50M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Bahija Jallal $10,885,268
Travis Coy $5,171,209
David Berman $4,278,988
Tina St. Leger $1,204,261
Fiscal 2024
Executive Total
Bahija Jallal $12,852,234
David Berman $5,481,495
Brian Di Donato $3,439,339
Tina St. Leger $1,115,871
Fiscal 2023
Executive Total
Bahija Jallal $11,678,834
David Berman $4,396,622
Brian Di Donato $3,354,443
Tina St. Leger $1,039,117
Fiscal 2022
Executive Total
Bahija Jallal $8,008,503
Fiscal 2021
Executive Total
Bahija Jallal $34,783,285

Executive changes

Person Change Filed
David Berman Resigned 2026-01-30
Tina St. Leger Resigned 2025-11-28
Ranjeev Krishana Resigned 2025-11-28
William Pao, M.D., Ph.D. Appointed 2025-02-26
Travis Coy Resigned 2025-01-02
Travis Coy Appointed 2025-01-02
Brian Di Donato Resigned 2024-08-29
Ranjeev Krishana Appointed 2024-05-28
Key facts CIK 1671927 CUSIP 45258D105 13F (30d) 135 filings 127 filers Visit website Investor relations